Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 69
Filter
Add more filters

Publication year range
1.
Eur Ann Allergy Clin Immunol ; 56(1): 17-25, 2024 Jan.
Article in English | MEDLINE | ID: mdl-36927838

ABSTRACT

Summary: Background. International guidelines suggested skin tests with Polyethylene-glycol (PEG) and polysorbate 80 (PS-80), to investigate a possible hypersensitivity to these excipients either to identify subjects at risk of developing allergic reactions to Covid-19 vaccines, or in patients with suspected IgE mediated hypersensitivity reactions (HR) to the Covid-19 vaccine. The main purpose of this study was to investigate the prevalence of PEG and PS sensitization in patients with a clinical history of HR to drugs containing PEG/PS and in patients with a suspected Covid-19 vaccine immediate HR. Methods. This was a multicenter retrospective study conducted by allergists belonging to 20 Italian medical centers. Skin testing was performed in 531 patients with either a clinical history of suspected hypersensitivity reaction (HR) to drugs containing PEG and/or PS-80 (group 1:362 patient) or a suspected HR to Covid-19 vaccines (group 2: 169 patient), as suggested by the AAIITO/SIAAIC guidelines for the "management of patients at risk of allergic reactions to Covid-19 vaccines" [1]. Results. 10/362 (0.02%) had positive skin test to one or both excipients in group 1, 12/169 (7.1%) in group 2 (p less than 0.01). In group 2 HRs to Covid-19 vaccines were immediate in 10/12 of cases and anaphylaxis occurred in 4/12 of patients. Conclusions. The positivity of skin test with PEG and or PS before vaccination is extremely rare and mostly replaceable by an accurate clinical history. Sensitization to PEG and PS has to be investigated in patients with a previous immediate HR to a Covid-19 vaccine, in particular in patients with anaphylaxis.


Subject(s)
Anaphylaxis , COVID-19 , Hypersensitivity, Immediate , Humans , Polysorbates/adverse effects , Polyethylene Glycols/adverse effects , COVID-19 Vaccines/adverse effects , COVID-19/epidemiology , COVID-19/prevention & control , Excipients/adverse effects , Anaphylaxis/diagnosis , Anaphylaxis/epidemiology , Retrospective Studies , Immunization Programs , Skin Tests , Italy/epidemiology
2.
Article in English | MEDLINE | ID: mdl-27164625

ABSTRACT

BACKGROUND AND OBJECTIVE: Administration of carbapenems to ß-lactam-allergic patients has always been considered potentially harmful because of a 47.4% rate of cross-reactivity to imipenem reported in a single study. Nevertheless, recent studies have shown that the rate of cross-reactivity of imipenem and meropenem with penicillins is lower than 1%. The aim of this study was to evaluate the possibility of using ertapenem in patients with an established IgE-mediated ß-lactam allergy. PATIENTS AND METHODS: We studied all participants who came to our allergy unit and had a clinical history of immediate hypersensitivity reactions to ß-lactams. The inclusion criteria were a positive skin test result to at least 1 ß-lactam molecule and/or positive specific IgE (when available). All participants underwent immediate-type skin tests with several ß-lactam molecules including ertapenem. Challenges with intravenous ertapenem were performed on 2 different days in patients with negative skin test results. RESULTS: We examined 49 patients with a clinical history of immediate reactions to ß-lactams. All the patients had positive skin tests and/or positive specific IgE to at least 1 ß-lactam reagent and negative carbapenem skin tests. Thirty-six patients agreed to undergo the challenges and 35 tolerated the full dose of ertapenem. CONCLUSIONS: The practice of avoiding carbapenems in patients with ß-lactam allergy should be abandoned considering the very low rate of cross-reactivity. ß-Lactam-allergic patients who need ertapenem therapy should undergo skin tests and, if negative, a graded challenge to assess tolerability.


Subject(s)
Anti-Bacterial Agents/adverse effects , Drug Hypersensitivity/diagnosis , Imipenem/adverse effects , Thienamycins/adverse effects , beta-Lactams/adverse effects , Adult , Aged , Cross Reactions , Drug Hypersensitivity/blood , Drug Hypersensitivity/etiology , Drug Hypersensitivity/immunology , Ertapenem , Female , Humans , Immunoglobulin E/blood , Male , Meropenem , Middle Aged , Skin Tests
3.
G Chir ; 37(1): 42-5, 2016.
Article in English | MEDLINE | ID: mdl-27142825

ABSTRACT

BACKGROUND: Posterior interosseous nerve (PIN) palsy may present with various symptoms, and may resemble cervical spondylosis. CASE REPORT: We report about a 59-year-old patient with cervical spondylosis which delayed the diagnosis of posterior interosseous nerve (PIN) palsy due to an intermuscular lipoma. Initial right hand paraesthesias and clumsiness, together with MR findings of right C5-C6 and C6-C7 foraminal stenosis, misled the diagnostic investigation. The progressive loss of extension of all right hand fingers brought to detect a painless mass compressing the PIN. Electrophysiological studies confirmed a right radial motor neuropathy at the level of the forearm. RESULTS: Surgical tumor removal and nerve decompression resulted in a gradual motor deficits recovery. CONCLUSIONS: A thorough clinical examination is paramount, and electrophysiology may differentiate between cervical and peripheral nerve lesions. Ultrasonography and MR offer an effective evaluation of lipomas, which represent a rare cause of PIN palsy. Surgical decompression and lipoma removal generally determine excellent prognoses, with very few recurrences.


Subject(s)
Lipoma/diagnosis , Nerve Compression Syndromes/etiology , Neurologic Examination , Radial Nerve/physiopathology , Soft Tissue Neoplasms/diagnosis , Spondylosis/complications , Cervical Vertebrae/diagnostic imaging , Decompression, Surgical , Diagnosis, Differential , Female , Forearm/innervation , Hand/innervation , Humans , Intervertebral Disc Displacement/complications , Intervertebral Disc Displacement/diagnostic imaging , Lipoma/complications , Lipoma/diagnostic imaging , Magnetic Resonance Imaging , Middle Aged , Nerve Compression Syndromes/surgery , Neural Conduction , Paresthesia/etiology , Soft Tissue Neoplasms/complications , Soft Tissue Neoplasms/diagnostic imaging , Spinal Cord Compression/etiology , Spondylosis/diagnostic imaging , Subcutaneous Fat/diagnostic imaging
4.
Pharmacogenomics J ; 13(2): 121-9, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22158329

ABSTRACT

Glucocorticoids (GCs) are steroid hormones widely used as pharmaceutical interventions, which act mainly by regulating gene expression levels. A large fraction of patients (∼30%), especially those of African descent, show a weak response to treatment. To interrogate the contribution of variable transcriptional response to inter-ethnic differences, we measured in vitro lymphocyte GC sensitivity (LGS) and transcriptome-wide response to GCs in peripheral blood mononuclear cells from African-American (AA) and European-American (EA) healthy donors. We found that transcriptional response after 8 h treatment was significantly correlated with variation in LGS within and between populations. We found that NFKB1, a gene previously found to predict LGS within populations, was more strongly downregulated in EAs on average. NFKB1 could not completely explain population differences, however, and we found an additional 177 genes with population differences in the average log2 fold change (false discovery rate<0.05), most of which also showed a weaker transcriptional response in AAs. These results suggest that inter-ethnic differences in GC sensitivity reflect variation in transcriptional response at many genes, including regulators with large effects (for example, NFKB1) and numerous other genes with smaller effects.


Subject(s)
Gene Expression Regulation/drug effects , Glucocorticoids/administration & dosage , Lymphocytes/cytology , Transcriptome , Black or African American/genetics , Glucocorticoids/metabolism , Humans , Lymphocytes/drug effects , NF-kappa B p50 Subunit/genetics , NF-kappa B p50 Subunit/metabolism , Transcriptional Activation/drug effects , White People/genetics
5.
Pharmacogenomics J ; 12(4): 287-96, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21358749

ABSTRACT

UGT2B enzymes metabolize multiple endogenous and exogenous molecules, including steroid hormones and clinical drugs. However, little is known about the inter-individual variation in gene expression and its determinants. We re-sequenced candidate regulatory regions and the partial coding regions (41.1 kb) of UGT2B genes and identified 332 genetic variants. We measured gene expression in normal breast and liver samples and observed different patterns. The expression levels varied greatly across individuals in both tissues and were significantly correlated with each other in liver. Genotyping of tagging single-nucleotide polymorphisms (SNPs) in the same samples and association tests between genotype and transcript levels identified 62 variants that were associated with at least one UGT2B mRNA levels in either tissue. Most of these cis-regulatory SNPs were not shared between tissues, suggesting that this gene family is regulated in a tissue-specific manner. Our results provide insight into studying the role of UGT2B variation in hormone-dependent cancers and drug response.


Subject(s)
Glucuronosyltransferase/genetics , Breast/metabolism , Female , Gene Expression Profiling , Humans , Liver/metabolism , Male , Polymorphism, Single Nucleotide , RNA, Messenger/metabolism , Regulatory Sequences, Nucleic Acid/genetics
6.
Annu Rev Nutr ; 30: 291-314, 2010 Aug 21.
Article in English | MEDLINE | ID: mdl-20420525

ABSTRACT

Through cultural innovation and changes in habitat and ecology, there have been a number of major dietary shifts in human evolution, including meat eating, cooking, and those associated with plant and animal domestication. The identification of signatures of adaptations to such dietary changes in the genome of extant primates (including humans) may shed light not only on the evolutionary history of our species, but also on the mechanisms that underlie common metabolic diseases in modern human populations. In this review, we provide a brief overview of the major dietary shifts that occurred during hominin evolution, and we discuss the methods and approaches used to identify signals of natural selection in patterns of sequence variation. We then review the results of studies aimed at detecting the genetic loci that played a major role in dietary adaptations and conclude by outlining the potential of future studies in this area.


Subject(s)
Adaptation, Physiological/physiology , Biological Evolution , Diet , Hominidae/genetics , Nutritional Physiological Phenomena/physiology , Adaptation, Physiological/genetics , Animals , Culture , Ecosystem , Genetic Variation , Genome , Humans , Nutritional Physiological Phenomena/genetics , Selection, Genetic
7.
Pharmacogenomics J ; 9(1): 49-60, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18825162

ABSTRACT

The CYP3A locus encodes hepatic enzymes that metabolize many clinically used drugs. However, there is marked interindividual variability in enzyme expression and clearance of drugs metabolized by these enzymes. We utilized comparative genomics and computational prediction of transcriptional factor binding sites to evaluate regions within CYP3A that were most likely to contribute to this variation. We then used a haplotype tagging single-nucleotide polymorphisms (htSNPs) approach to evaluate the entire locus with the fewest number of maximally informative SNPs. We investigated the association between these htSNPs and in vivo CYP3A enzyme activity using a single-point IV midazolam clearance assay. We found associations between the midazolam phenotype and age, diagnosis of hypertension and one htSNP (141689) located upstream of CYP3A4. 141689 lies near the xenobiotic responsive enhancer module (XREM) regulatory region of CYP3A4. Cell-based studies show increased transcriptional activation with the minor allele at 141689, in agreement with the in vivo association study findings. This study marks the first systematic evaluation of coding and noncoding variation that may contribute to CYP3A phenotypic variability.


Subject(s)
Black or African American/genetics , Cytochrome P-450 CYP3A/genetics , Haplotypes , Polymorphism, Single Nucleotide , Adult , Aged , Aged, 80 and over , Cell Line, Tumor , Cytochrome P-450 CYP3A/metabolism , Female , Gene Frequency , Humans , Linkage Disequilibrium , Male , Midazolam/pharmacokinetics , Middle Aged , Predictive Value of Tests , Transfection , Young Adult
8.
Acta Neurochir (Wien) ; 150(10): 1057-65; discussion 1065, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18773140

ABSTRACT

BACKGROUND: Meningoencephalitis may sometimes cause medically refractory intracranial hypertension and brain herniation. In such patients death is common. There are a limited number of reports on the use of decompressive craniectomy as a life saving measure in these circumstances with some good results. The aim of the study was to report experience in three further patients. MATERIALS AND METHODS: In a 15-month period, three patients affected by acute meningoencephalitis were surgically treated by decompressive craniectomy at the Department of Neurosurgery of the Polytechnic University of Ancona. In all patients common symptoms at presentation were headache, fever and neck rigidity, rapidly followed by the development of focal neurological deficits and coma. Intracranial pressure monitoring was always performed and correlated with serial CT scan examinations. Because of the development of severe intracranial hypertension refractory to conventional medical treatment, a decompressive hemicraniectomy was performed in two patients and a bifrontal decompressive craniectomy in the third one. Bacterial meningoencephalitis was diagnosed in two patients, viral meningoencephalitis in the remaining one. FINDINGS: One patient died 3 days after surgery. The remaining two completely recovered consciousness, with no residual focal neurological deficit. CONCLUSIONS: Surgery resulted in an immediate reduction of intracranial pressure in two of the three patients with severe meningoencephalitis. Decompressive craniectomy may be a useful option in the management of a patient with medically refractory intracranial hypertension caused by meningoencephalitis. Early intervention may enhance its benefits.


Subject(s)
Brain/pathology , Craniotomy/methods , Decompression, Surgical/methods , Intracranial Hypertension/surgery , Meningoencephalitis/complications , Adult , Anti-Bacterial Agents/therapeutic use , Antiviral Agents/therapeutic use , Brain/diagnostic imaging , Brain/microbiology , Brain Edema/microbiology , Brain Edema/physiopathology , Brain Edema/surgery , Dura Mater/anatomy & histology , Dura Mater/surgery , Encephalitis, Herpes Simplex/complications , Encephalitis, Herpes Simplex/drug therapy , Encephalitis, Herpes Simplex/pathology , Fatal Outcome , Hernia/microbiology , Hernia/physiopathology , Herniorrhaphy , Humans , Intracranial Hypertension/microbiology , Intracranial Hypertension/physiopathology , Magnetic Resonance Imaging , Male , Meningitis, Bacterial/complications , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/pathology , Meningoencephalitis/microbiology , Meningoencephalitis/pathology , Middle Aged , Skull/anatomy & histology , Skull/surgery , Streptococcal Infections/complications , Streptococcal Infections/drug therapy , Streptococcal Infections/pathology , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
9.
Trends Genet ; 16(7): 296-302, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10858659

ABSTRACT

Studies of nuclear sequence variation are accumulating, such that we can expect a good description of the structure of human variation across populations and genomic regions in the near future. This description will help to elucidate the evolutionary forces that shape patterns of variability. Such an understanding will be of general biological interest, but could also facilitate the design and interpretation of disease-mapping studies. Here, we integrate the results from surveys of nuclear sequence variation. When nuclear sequences are considered together with mtDNA and microsatellites, it becomes clear that neither the standard neutral model, nor a simple long-term exponential growth model, can account for all the available human variation data. A possible explanation is that a subset of loci are not evolving neutrally; even so, more-complex models of effective population size and structure might be necessary to explain the data.


Subject(s)
Genetic Variation , Genetics, Medical , Biological Evolution , Humans , Selection, Genetic
10.
Eur Ann Allergy Clin Immunol ; 39(3): 101-3, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17465282

ABSTRACT

Allergen specific immunotherapy is an important option for the treatment of respiratory allergy and its clinical efficacy has been clearly demonstrated by several studies. However, the injective route of administration and the possibility of severe side effects has limited its use in children and led to the introduction of new forms of administration. Sublingual immunotherapy (SLIT) has proven to be an effective and safe treatment for respiratory allergy. However, its mechanism of action is still debated. Pharmacokinetic studies showed that, differently from nasal mucosa, allergen extracts administered by SLIT are not immediately adsorbed but are long retained before being drained to local lymph nodes. This difference may be responsible of the absence of severe side effects and instead of short-lasting local symptoms. Studies by biopsies of the oral mucosa should greatly help in defining the presence and the role of cells involved in the mechanisms of oral tolerance.


Subject(s)
Allergens/administration & dosage , Desensitization, Immunologic/methods , Administration, Sublingual , Allergens/pharmacokinetics , Humans , Mouth Mucosa/immunology
SELECTION OF CITATIONS
SEARCH DETAIL